Vir Biotechnology Inc (VIR)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Gross profit (ttm)	US$ in thousands	83,415	110,840	460,543	388,218	1,469,478	2,181,934	1,925,410	2,169,884	1,029,550	275,414	181,562	72,626	76,368	75,614	65,869
Revenue (ttm)	US$ in thousands	86,180	118,803	490,721	444,237	1,613,740	2,377,077	2,106,136	2,325,891	1,095,407	284,394	182,706	72,626	76,368	75,614	75,089
Gross profit margin		96.79%	93.30%	93.85%	87.39%	91.06%	91.79%	91.42%	93.29%	93.99%	96.84%	99.37%	100.00%	100.00%	100.00%	87.72%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $83,415K ÷ $86,180K
= 96.79%

The gross profit margin of Vir Biotechnology Inc has displayed some fluctuations over the quarters provided. The company's gross profit margin ranged from 86.99% to 96.79% during the period. Generally, the company has maintained a high gross profit margin, which indicates that Vir Biotechnology has been effectively managing its production costs and generating significant profits from its core operations.

The highest gross profit margin of 96.79% was recorded in Q4 2023, reflecting a strong efficiency in producing goods or services at a lower cost compared to their selling price. Conversely, the lowest gross profit margin of 86.99% was observed in Q1 2023, suggesting possibly higher production costs or lower revenue during that quarter.

Overall, the trend seems to indicate a relatively healthy gross profit margin performance for Vir Biotechnology Inc, with some variability from quarter to quarter. Further analysis and comparisons with industry peers could provide additional insights into the company's operational efficiency and competitiveness.